\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ presented\\ with\\ drowsiness\\,\\ weariness\\ in\\ upper\\ and\\ lower\\ limbs\\ and\\ gait\\ difficulties\\.\ \(0\)\
\-\ bp\\ 180\\/110\\ mmhg\ \(0\)\
\-\ mri\\ findings\\ of\\ bilateral\\ and\\ symmetric\\ basal\\ ganglia\\ involvement\\,\\ but\\ diagnosis\\ of\\ exclusion\\ after\\ ruling\\ out\\ \\(by\\ laboratory\\ and\\ clinical\\ and\\ mri\\ evolution\\)\\ of\\ other\\ possible\\ causes\\.\\ after\\ recovering\\ from\\ the\\ hellp\\ syndrome\\,\\ pre\\-eclampsia\\ and\\ normalization\\ of\\ the\\ high\\-blood\\ pressure\\,\\ the\\ patient\\ experienced\\ a\\ quick\\ and\\ complete\\ recovery\\.\\ subsequent\\ mri\\ 2\\ weeks\\ later\\ was\\ completely\\ normal\\.\ \(0\)\
\-\ anti\\-hypertensive\\ and\\ supportive\\ treatment\\ with\\ favorable\\ evolution\\.\ \(0\)\
\-\ lentiform\\ fork\\ sign\\ in\\ hellp\\ syndrome\\.\\ bilateral\\ symmetric\\ hypodensity\\ of\\ the\\ basal\\ ganglia\\ on\\ non\\-enhanced\\ ct\\,\\ without\\ enhancement\\ after\\ contrast\\ administration\\.\\ subsequent\\ mri\\ showed\\ hypointense\\ areas\\ on\\ t1wi\\ and\\ high\\ intensity\\ on\\ t2wi\\ and\\ flair\\,\\ consistent\\ with\\ vasogenic\\ edema\\ involving\\ symmetrically\\ globus\\ pallidus\\,\\ putamen\\,\\ internal\\ and\\ external\\ capsules\\,\\ but\\ tiny\\ areas\\ of\\ diffusion\\ restriction\\ were\\ present\\.\ \(0\)\
\-\ follow\\-up\\ mri\\ 2\\ weeks\\ later\\ showed\\ complete\\ resolution\\ of\\ the\\ imaging\\ findings\\.\ \(0\)\
\-\ lentiform\\ fork\\ sign\\ of\\ basal\\ ganglia\\ in\\ hellp\\ syndrome\\.\ \(0\)\
\-\ acute\\ uremic\\ encephalopathies\\,\\ typically\\ acute\\ glomerulonephritis\\,\\ hemolytic\\-uremic\\ syndrome\\ and\\ thrombotic\\ thrombocytopenic\\ purpura\\.\ \(0\)\
\-\ systemic\\ metabolic\\ acidosis\\.\ \(0\)\
\-\ toxins\\ such\\ as\\ methanol\\ and\\ carbon\\ monoxide\\.\ \(0\)\
\-\ etiologies\\ of\\ acute\\ hypoxia\\.\ \(0\)\
\-\ metabolic\\ conditions\\ as\\ mitochondrial\\ disorders\\ could\\ also\\ be\\ included\\ in\\ the\\ differential\\.\ \(0\)\
\-\ symmetric\\ vasculitis\\-like\\ processes\\ related\\ to\\ tuberculosis\\ and\\ fungal\\ basal\\ meningitis\\ could\\ also\\ involve\\ bilaterally\\ the\\ basal\\ ganglia\\.\ \(0\)\
\-\ deep\\ veins\\ thrombosis\\.\ \(0\)\
\-\ 24\\ y\\.o\\.\\ woman\\ with\\ hellp\\ syndrome\\ \\(hemolysis\\,\\ elevated\\ liver\\,\\ low\\ platelets\\)\\ and\\ severe\\ pre\\-eclampsia\\ with\\ high\\ blood\\ pressure\\ \\(180\\/110\\ mmhg\\)\\.\ \(0\)\
\-\ lentiform\\ fork\\ sign\\ was\\ classically\\ described\\ in\\ acute\\ uremic\\ encephalopathies\\ and\\ it\\ was\\ explained\\ by\\ both\\ acute\\ uremia\\ and\\ associated\\ metabolic\\ acidosis\\.\\ acute\\ uremic\\ encephalopathies\\ in\\ which\\ this\\ sign\\ was\\ typically\\ described\\ included\\ acute\\ glomerulonephritis\\,\\ hemolytic\\-uremic\\ syndrome\\ and\\ thrombotic\\ thrombocytopenic\\ purpura\\.\\ \ \(0\)\
\-\ classical\\ described\\ mri\\ findings\\ were\\ relatively\\ symmetric\\ edema\\ in\\ the\\ globus\\ pallidus\\ and\\ putamen\\,\\ with\\ extension\\ to\\ the\\ internal\\ and\\ external\\ capsules\\,\\ associated\\ with\\ some\\ mass\\ effect\\.\ \(0\)\
\-\ the\\ differential\\ diagnosis\\ includes\\ hypoxia\\ and\\ toxins\\ as\\ methanol\\ and\\ carbon\\ monoxide\\.\\ metabolic\\ conditions\\ as\\ mitochondrial\\ disorders\\ could\\ also\\ be\\ included\\ in\\ the\\ differential\\.\\ symmetric\\ vasculitis\\-like\\ processes\\ related\\ to\\ tuberculosis\\ and\\ fungal\\ basal\\ meningitis\\ could\\ also\\ involve\\ bilateraly\\ the\\ basal\\ ganglia\\.\ \(0\)\
\-\ http\\:\\/\\/www\\.aafp\\.org\\/afp\\/1999\\/0901\\/p829\\.html\ \(1\)\
\-\ references\\:\ \(0\)\
\-\ rathi\\ m\\,\\ mudrabettu\\ c\\.\\ lentiform\\ fork\\ sign\\ in\\ a\\ case\\ of\\ end\\-stage\\ renal\\ disease\\.\\ kidney\\ international\\ 2012\\;\\ 82\\,\\ 365\\.\ \(0\)\
\-\ jeong\\ yk\\,\\ kim\\ lo\\,\\ kim\\ ws\\,\\ et\\ al\\.\\ hemolytic\\ uremic\\ syndrome\\:\\ mr\\ findings\\ of\\ cns\\ complications\\.\\ pediatr\\ radiol\\ 1994\\;\\ 24\\:585\\-586\\.\ \(0\)\
\-\ moore\\ kr\\,\\ osborn\\ ag\\,\\ townsend\\ jj\\,\\ et\\ al\\.\\ the\\ imaging\\ and\\ pathologic\\ spectrum\\ of\\ hus\\-tfp\\.\\ j\\ neuroradiol\\ 1997\\;\\ 3\\:147\\-159\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ uremic\\:\\ 0\\.3232190575477684\ \(0\)\
\-\ hellp\\:\\ 0\\.22550218001951197\ \(0\)\
\-\ fork\\:\\ 0\\.22550218001951197\ \(0\)\
\-\ basal\\:\\ 0\\.21115431283676325\ \(0\)\
\-\ lentiform\\:\\ 0\\.1983452677027119\ \(0\)\
\-\ and\\:\\ 0\\.17482522111715645\ \(0\)\
\-\ ganglia\\:\\ 0\\.16565999425462524\ \(0\)\
\-\ encephalopathies\\:\\ 0\\.15627605701778371\ \(0\)\
\-\ symmetric\\:\\ 0\\.15104760839523126\ \(0\)\
\-\ syndrome\\:\\ 0\\.14876424733029586\ \(0\)\
\-\ acute\\:\\ 0\\.1334897064674828\ \(0\)\
\-\ hemolytic\\:\\ 0\\.1317714106874562\ \(0\)\
\-\ metabolic\\:\\ 0\\.1278302530670917\ \(0\)\
\-\ sign\\:\\ 0\\.12202672154086625\ \(0\)\
\-\ mri\\:\\ 0\\.10857134429974061\ \(0\)\
\-\ could\\:\\ 0\\.10256625721340656\ \(0\)\
\-\ the\\:\\ 0\\.09847658366050972\ \(0\)\
\-\ capsules\\:\\ 0\\.09726738641382769\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.09726738641382769\ \(0\)\
\-\ methanol\\:\\ 0\\.09561698601395564\ \(0\)\
\-\ mitochondrial\\:\\ 0\\.09561698601395564\ \(0\)\
\-\ toxins\\:\\ 0\\.0941612296908561\ \(0\)\
\-\ pallidus\\:\\ 0\\.09168101144761048\ \(0\)\
\-\ kim\\:\\ 0\\.09168101144761048\ \(0\)\
\-\ included\\:\\ 0\\.09145267694011515\ \(0\)\
\-\ glomerulonephritis\\:\\ 0\\.08961628252724636\ \(0\)\
\-\ purpura\\:\\ 0\\.08961628252724636\ \(0\)\
\-\ putamen\\:\\ 0\\.0878476071249708\ \(0\)\
\-\ monoxide\\:\\ 0\\.0878476071249708\ \(0\)\
\-\ globus\\:\\ 0\\.08630063530717973\ \(0\)\
\-\ described\\:\\ 0\\.08580585465169137\ \(0\)\
\-\ thrombotic\\:\\ 0\\.08559417769295592\ \(0\)\
\-\ carbon\\:\\ 0\\.08492592611667418\ \(0\)\
\-\ of\\:\\ 0\\.08278381078231403\ \(0\)\
\-\ evolution\\:\\ 0\\.08256455151439272\ \(0\)\
\-\ acidosis\\:\\ 0\\.08013328241802734\ \(0\)\
\-\ in\\:\\ 0\\.07892587341880605\ \(0\)\
\-\ hypoxia\\:\\ 0\\.07773358330927956\ \(0\)\
\-\ mmhg\\:\\ 0\\.07635887411877401\ \(0\)\
\-\ findings\\:\\ 0\\.06959300834210552\ \(0\)\
\-\ processes\\:\\ 0\\.06934964048910426\ \(0\)\
\-\ differential\\:\\ 0\\.06871503036657792\ \(0\)\
\-\ meningitis\\:\\ 0\\.0664085565828944\ \(0\)\
\-\ also\\:\\ 0\\.06632603097322329\ \(0\)\
\-\ conditions\\:\\ 0\\.06439988056328518\ \(0\)\
\-\ fungal\\:\\ 0\\.06311002798527686\ \(0\)\
\-\ disorders\\:\\ 0\\.06224987971335125\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.062043880887564795\ \(0\)\
\-\ involve\\:\\ 0\\.062043880887564795\ \(0\)\
\-\ high\\:\\ 0\\.060104698657990854\ \(0\)\
\-\ external\\:\\ 0\\.05699847493551771\ \(0\)\
\-\ as\\:\\ 0\\.05664784027580628\ \(0\)\
\-\ weariness\\:\\ 0\\.05637554500487799\ \(0\)\
\-\ hemolysis\\:\\ 0\\.05637554500487799\ \(0\)\
\-\ mudrabettu\\:\\ 0\\.05637554500487799\ \(0\)\
\-\ yk\\:\\ 0\\.05637554500487799\ \(0\)\
\-\ al\\:\\ 0\\.056019627739683775\ \(0\)\
\-\ et\\:\\ 0\\.05522979953324216\ \(0\)\
\-\ townsend\\:\\ 0\\.05386984292462806\ \(0\)\
\-\ pressure\\:\\ 0\\.053682827715451076\ \(0\)\
\-\ related\\:\\ 0\\.05357939913337013\ \(0\)\
\-\ subsequent\\:\\ 0\\.053375102855066546\ \(0\)\
\-\ drowsiness\\:\\ 0\\.05209201900592791\ \(0\)\
\-\ bilateraly\\:\\ 0\\.05209201900592791\ \(0\)\
\-\ 365\\:\\ 0\\.05209201900592791\ \(0\)\
\-\ lo\\:\\ 0\\.05209201900592791\ \(0\)\
\-\ kr\\:\\ 0\\.05209201900592791\ \(0\)\
\-\ after\\:\\ 0\\.05130389883302949\ \(0\)\
\-\ later\\:\\ 0\\.05045608814889058\ \(0\)\
\-\ 24\\:\\ 0\\.04998518763463012\ \(0\)\
\-\ uremia\\:\\ 0\\.04958631692567798\ \(0\)\
\-\ ws\\:\\ 0\\.04958631692567798\ \(0\)\
\-\ typically\\:\\ 0\\.04949451139901208\ \(0\)\
\-\ complete\\:\\ 0\\.04942072226382696\ \(0\)\
\-\ was\\:\\ 0\\.049142616594295266\ \(0\)\
\-\ quick\\:\\ 0\\.048633693206913846\ \(0\)\
\-\ with\\:\\ 0\\.048319409885559265\ \(0\)\
\-\ areas\\:\\ 0\\.0478672607407503\ \(0\)\
\-\ normalization\\:\\ 0\\.04780849300697782\ \(0\)\
\-\ jj\\:\\ 0\\.04780849300697782\ \(0\)\
\-\ internal\\:\\ 0\\.047515474826298684\ \(0\)\
\-\ ruling\\:\\ 0\\.04708061484542805\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.04708061484542805\ \(0\)\
\-\ showed\\:\\ 0\\.04696058468045324\ \(0\)\
\-\ osborn\\:\\ 0\\.04642950564273534\ \(0\)\
\-\ pediatr\\:\\ 0\\.0439238035624854\ \(0\)\
\-\ ag\\:\\ 0\\.0439238035624854\ \(0\)\
\-\ recovering\\:\\ 0\\.043524967008027736\ \(0\)\
\-\ symmetrically\\:\\ 0\\.04315031765358986\ \(0\)\
\-\ classical\\:\\ 0\\.04279708884647796\ \(0\)\
\-\ international\\:\\ 0\\.04279708884647796\ \(0\)\
\-\ radiol\\:\\ 0\\.04279708884647796\ \(0\)\
\-\ weeks\\:\\ 0\\.04225437240698497\ \(0\)\
\-\ edema\\:\\ 0\\.0420500761286814\ \(0\)\
\-\ restriction\\:\\ 0\\.041556979724855156\ \(0\)\
\-\ explained\\:\\ 0\\.041556979724855156\ \(0\)\
\-\ limbs\\:\\ 0\\.04128227575719636\ \(0\)\
\-\ exclusion\\:\\ 0\\.04128227575719636\ \(0\)\
\-\ blood\\:\\ 0\\.040945975724323985\ \(0\)\
\-\ favorable\\:\\ 0\\.04029138676622803\ \(0\)\
\-\ difficulties\\:\\ 0\\.04006664120901367\ \(0\)\
\-\ 1994\\:\\ 0\\.04006664120901367\ \(0\)\
\-\ platelets\\:\\ 0\\.03984978310879371\ \(0\)\
\-\ tiny\\:\\ 0\\.03905127764460522\ \(0\)\
\-\ t1wi\\:\\ 0\\.038513562847527875\ \(0\)\
\-\ 2012\\:\\ 0\\.038513562847527875\ \(0\)\
\-\ hypodensity\\:\\ 0\\.038344242071838446\ \(0\)\
\-\ bilateral\\:\\ 0\\.03789139925913824\ \(0\)\
\-\ t2wi\\:\\ 0\\.03770985770131937\ \(0\)\
\-\ associated\\:\\ 0\\.03716084406771096\ \(0\)\
\-\ imaging\\:\\ 0\\.03705218716190922\ \(0\)\
\-\ classically\\:\\ 0\\.036865845244188615\ \(0\)\
\-\ diagnosis\\:\\ 0\\.036548723719650726\ \(0\)\
\-\ were\\:\\ 0\\.036342724893864274\ \(0\)\
\-\ 82\\:\\ 0\\.03589446636166258\ \(0\)\
\-\ spectrum\\:\\ 0\\.03578311521006358\ \(0\)\
\-\ etiologies\\:\\ 0\\.03535675156458523\ \(0\)\
\-\ but\\:\\ 0\\.03486429031957201\ \(0\)\
\-\ 1997\\:\\ 0\\.03486210190148052\ \(0\)\
\-\ recovery\\:\\ 0\\.03467482024455213\ \(0\)\
\-\ vasogenic\\:\\ 0\\.03467482024455213\ \(0\)\
\-\ experienced\\:\\ 0\\.033502158687028015\ \(0\)\
\-\ cns\\:\\ 0\\.03292009849001327\ \(0\)\
\-\ on\\:\\ 0\\.03194008343352192\ \(0\)\
\-\ completely\\:\\ 0\\.031499589211113496\ \(0\)\
\-\ systemic\\:\\ 0\\.03128273111089354\ \(0\)\
\-\ veins\\:\\ 0\\.03128273111089354\ \(0\)\
\-\ hypointense\\:\\ 0\\.031021940443782398\ \(0\)\
\-\ gait\\:\\ 0\\.03053122071512886\ \(0\)\
\-\ flair\\:\\ 0\\.02998957598360034\ \(0\)\
\-\ by\\:\\ 0\\.02994004635439041\ \(0\)\
\-\ diffusion\\:\\ 0\\.029694238201392657\ \(0\)\
\-\ supportive\\:\\ 0\\.029451861186522998\ \(0\)\
\-\ pathologic\\:\\ 0\\.028884506899937056\ \(0\)\
\-\ thrombosis\\:\\ 0\\.028741614482628523\ \(0\)\
\-\ relatively\\:\\ 0\\.028706401728004892\ \(0\)\
\-\ bp\\:\\ 0\\.02860195155056379\ \(0\)\
\-\ resolution\\:\\ 0\\.02860195155056379\ \(0\)\
\-\ be\\:\\ 0\\.028600614947948393\ \(0\)\
\-\ references\\:\\ 0\\.028104646754564876\ \(0\)\
\-\ administration\\:\\ 0\\.028072873822280502\ \(0\)\
\-\ deep\\:\\ 0\\.02744080876937777\ \(0\)\
\-\ includes\\:\\ 0\\.027412264507469072\ \(0\)\
\-\ complications\\:\\ 0\\.026999205111943456\ \(0\)\
\-\ causes\\:\\ 0\\.02663710362316926\ \(0\)\
\-\ to\\:\\ 0\\.026438755975088185\ \(0\)\
\-\ http\\:\\ 0\\.026061821405135285\ \(0\)\
\-\ laboratory\\:\\ 0\\.025598944674314946\ \(0\)\
\-\ involvement\\:\\ 0\\.02551457719720096\ \(0\)\
\-\ intensity\\:\\ 0\\.025031217828770876\ \(0\)\
\-\ extension\\:\\ 0\\.024954209708098876\ \(0\)\
\-\ kidney\\:\\ 0\\.024765785913438414\ \(0\)\
\-\ effect\\:\\ 0\\.02472878088240947\ \(0\)\
\-\ involving\\:\\ 0\\.02469199612072699\ \(0\)\
\-\ liver\\:\\ 0\\.024318425551613704\ \(0\)\
\-\ elevated\\:\\ 0\\.024031724838200087\ \(0\)\
\-\ possible\\:\\ 0\\.02388516093197746\ \(0\)\
\-\ bilaterally\\:\\ 0\\.023510511577539587\ \(0\)\
\-\ out\\:\\ 0\\.02317160449576276\ \(0\)\
\-\ patient\\:\\ 0\\.022931380344800783\ \(0\)\
\-\ mr\\:\\ 0\\.022809619579904697\ \(0\)\
\-\ such\\:\\ 0\\.02267585198234439\ \(0\)\
\-\ clinical\\:\\ 0\\.022341029758555498\ \(0\)\
\-\ severe\\:\\ 0\\.022316010203262543\ \(0\)\
\-\ some\\:\\ 0\\.02218018447822343\ \(0\)\
\-\ renal\\:\\ 0\\.021952386403428507\ \(0\)\
\-\ presented\\:\\ 0\\.020556941448324293\ \(0\)\
\-\ enhancement\\:\\ 0\\.020290409687246803\ \(0\)\
\-\ low\\:\\ 0\\.02022776070463085\ \(0\)\
\-\ both\\:\\ 0\\.01965821969986143\ \(0\)\
\-\ consistent\\:\\ 0\\.019114417407578778\ \(0\)\
\-\ upper\\:\\ 0\\.01883809699730759\ \(0\)\
\-\ without\\:\\ 0\\.018594079103979942\ \(0\)\
\-\ woman\\:\\ 0\\.01835933166200598\ \(0\)\
\-\ other\\:\\ 0\\.018306904440113982\ \(0\)\
\-\ present\\:\\ 0\\.018088921324559647\ \(0\)\
\-\ it\\:\\ 0\\.01804498132023202\ \(0\)\
\-\ lower\\:\\ 0\\.01801378578848527\ \(0\)\
\-\ case\\:\\ 0\\.017710197158712145\ \(0\)\
\-\ contrast\\:\\ 0\\.017128203535592964\ \(0\)\
\-\ treatment\\:\\ 0\\.01679237508268965\ \(0\)\
\-\ which\\:\\ 0\\.016029413139848805\ \(0\)\
\-\ disease\\:\\ 0\\.01479751695280741\ \(0\)\
\-\ normal\\:\\ 0\\.014393135470462072\ \(0\)\
\-\ from\\:\\ 0\\.014000580654037005\ \(0\)\
\-\ mass\\:\\ 0\\.013465304458128902\ \(0\)\
\-\ ct\\:\\ 0\\.01342074895354342\ \(0\)\
\-\ this\\:\\ 0\\.012113205410632284\ \(0\)\
